What is Viveve?
Viveve Medical, Inc., established in 2005 and based in Englewood, Colorado, is dedicated to advancing women's health through the development and production of non-invasive medical devices. The company's core focus lies in creating innovative treatments for intimate health conditions, aiming to enhance the quality of life for women by leveraging cutting-edge medical technology. Viveve's approach integrates deep medical expertise with technological innovation to deliver solutions for previously underserved areas within women's healthcare.
How much funding has Viveve raised?
Viveve has raised a total of $210.8M across 21 funding rounds:
Debt
$500K
Share Placement
$6M
Share Placement
$12M
Share Placement
$6M
Stock Offering
$15.5M
Debt
$10M
Stock Offering
$31.7M
Debt
$30M
Stock Offering
$32.4M
Stock Offering
$18.8M
Stock Offering
$6.8M
Stock Offering
$11.5M
Multiple Rounds
$7.6M
Debt (2014): $500K, investors not publicly disclosed
Share Placement (2014): $6M supported by 5AM Ventures, Alta BioEquities, and GBS Venture Partners
Share Placement (2015): $12M featuring 5AM Ventures, Stonepine Capital, and Alta Bioequities
Share Placement (2015): $6M backed by Wexford Capital LP, Stonepine Capital, RTW Investments, Alta Bioequities, and Manchester Management Company
Stock Issuance/Offering (2016): $15.5M, investors not publicly disclosed
Debt (2016): $10M led by Bridge Bank
Stock Issuance/Offering (2017): $31.7M, investors not publicly disclosed
Debt (2017): $30M featuring CRG LP
Stock Issuance/Offering (2018): $32.4M, investors not publicly disclosed
Stock Issuance/Offering (2018): $18.8M, investors not publicly disclosed
Stock Issuance/Offering (2019): $6.8M, investors not publicly disclosed
Stock Issuance/Offering (2019): $11.5M, investors not publicly disclosed
Debt (2020): $1M featuring PPP
Other Financing Round (2020): $3M, investors not publicly disclosed
Other Financing Round (2020): $3.6M, investors not publicly disclosed
Key Investors in Viveve
5AM Ventures
Five AM Ventures is a life science focused venture capital firm that backs early stage biotech and health care innovators, partnering closely with founders to shape companies, fund rigorous science and help bring new therapies and technologies to patients.
GBS Venture Partners
GBS Venture Partners is a venture capital firm that focuses on investing in innovative healthcare companies. They aim to support entrepreneurs in the development of groundbreaking medical solutions. Their portfolio includes companies involved in pharmaceuticals and medical devices, targeting various health conditions. GBS Venture Partners is dedicated to advancing healthcare through strategic investments and partnerships.
CRG LP
CR Group L.P. (CRG) is a global investment firm focused on enhancing healthcare through flexible growth capital solutions. With over $4 billion in institutional capital, CRG specializes in credit and select equity investments across consumer health, life sciences, and healthcare services & IT. The firm leverages decades of experience to create tailored financial strategies that foster sustainable growth for its partners. CRG's dedicated team provides a dynamic array of financing solutions, making it a premier investment partner in the healthcare sector.
What's next for Viveve?
The recent major strategic investment positions Viveve for accelerated expansion and further innovation in the women's health sector. This capital infusion is expected to fuel advancements in product development, enhance market penetration, and potentially support clinical research to validate and broaden the application of their technologies. As a company operating in a critical yet often overlooked segment of healthcare, Viveve's strategic financing indicates a strong trajectory for growth and a commitment to making a significant impact on women's well-being through its specialized medical devices.
See full Viveve company page
